63 related articles for article (PubMed ID: 10657879)
1. High-dose intense chemotherapy in South African children with B-cell lymphoma: morbidity, supportive measures, and outcome.
Hesseling PB
Med Pediatr Oncol; 2000 Feb; 34(2):143-6. PubMed ID: 10657879
[TBL] [Abstract][Full Text] [Related]
2. Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol.
Atra A; Imeson JD; Hobson R; Gerrard M; Hann IM; Eden OB; Carter RL; Pinkerton CR
Br J Cancer; 2000 Apr; 82(8):1396-402. PubMed ID: 10780517
[TBL] [Abstract][Full Text] [Related]
3. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
[TBL] [Abstract][Full Text] [Related]
4. Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.
Gerrard M; Cairo MS; Weston C; Auperin A; Pinkerton R; Lambilliote A; Sposto R; McCarthy K; Lacombe MJ; Perkins SL; Patte C;
Br J Haematol; 2008 Jun; 141(6):840-7. PubMed ID: 18371107
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92).
Pillon M; Di Tullio MT; Garaventa A; Cesaro S; Putti MC; Favre C; Lippi A; Surico G; Di Cataldo A; D'Amore E; Zanesco L; Rosolen A
Cancer; 2004 Jul; 101(2):385-94. PubMed ID: 15241838
[TBL] [Abstract][Full Text] [Related]
6. Malawi pilot study of Burkitt lymphoma treatment.
Hesseling PB; Broadhead R; Molyneux E; Borgstein E; Schneider JW; Louw M; Mansvelt EP; Wessels G
Med Pediatr Oncol; 2003 Dec; 41(6):532-40. PubMed ID: 14595710
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
[TBL] [Abstract][Full Text] [Related]
8. Burkitt lymphoma in children: the Israeli experience.
Eldar AH; Futerman B; Abrahami G; Attias D; Barak AB; Burstein Y; Dvir R; Gabriel H; Horovitz J; Kapelushnik J; Kaplinsky H; Miskin H; Sthoeger D; Toren A; Vilk-Revel S; Weintraub M; Yaniv I; Linn S; Arush MB
J Pediatr Hematol Oncol; 2009 Jun; 31(6):428-36. PubMed ID: 19648792
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of extensive B-cell lymphoma in children: studies of the French Pediatric Oncology Society].
Vannier JP; Patte C; Philip T; Zucker JM; Gentet JC; Lamagnière JP; Pein F; Rodary C
Bull Cancer; 1988; 75(1):61-8. PubMed ID: 3258775
[TBL] [Abstract][Full Text] [Related]
10. The 2000 Burkitt lymphoma trial in Malawi.
Hesseling P; Broadhead R; Mansvelt E; Louw M; Wessels G; Borgstein E; Schneider J; Molyneux E
Pediatr Blood Cancer; 2005 Mar; 44(3):245-50. PubMed ID: 15547922
[TBL] [Abstract][Full Text] [Related]
11. Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi.
Israëls T; van de Wetering MD; Hesseling P; van Geloven N; Caron HN; Molyneux EM
Pediatr Blood Cancer; 2009 Jul; 53(1):47-52. PubMed ID: 19338050
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca].
Madani A; Benhmiddoune L; Zafad S; Harif M; Quessar A; Benchekroun S
Bull Cancer; 2005 Feb; 92(2):193-8. PubMed ID: 15749649
[TBL] [Abstract][Full Text] [Related]
13. Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897).
Todeschini G; Tecchio C; Pasini F; Benedetti F; Cantini M; Crippa C; Draisci M; Pizzolo G
Cancer; 2005 Aug; 104(3):555-60. PubMed ID: 15959910
[TBL] [Abstract][Full Text] [Related]
14. Treatment of B-cell lymphoma with LMB modified protocols in Africa--report of the French-African Pediatric Oncology Group (GFAOP).
Harif M; Barsaoui S; Benchekroun S; Bouhas R; Doumbé P; Khattab M; Ladjaj Y; Moreira C; Msefer-Alaoui F; Patte C; Rakotonirina G; Raphael M; Raquin MA; Lemerle J
Pediatr Blood Cancer; 2008 Jun; 50(6):1138-42. PubMed ID: 18213709
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of short-term and intensive chemotherapy for the treatment of childhood and adolescent B cell non-Hodgkin's lymphoma].
Sun XF; Liu DG; Zhen ZJ; Chen XQ; Xia Y; Wang ZH; He YJ; Guan ZG
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):581-4. PubMed ID: 16532964
[TBL] [Abstract][Full Text] [Related]
16. Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa.
Wessels G; Bernard Hesseling P
Transfus Apher Sci; 2005 Feb; 32(1):27-31. PubMed ID: 15737871
[TBL] [Abstract][Full Text] [Related]
17. Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol.
Sun XF; Zhen ZJ; Lui DG; Xia Y; He YJ; Wang ZH; Lin JY; Guan ZZ
Eur J Haematol; 2006 Nov; 77(5):365-71. PubMed ID: 16879606
[TBL] [Abstract][Full Text] [Related]
18. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
Mora J; Filippa DA; Qin J; Wollner N
Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
[TBL] [Abstract][Full Text] [Related]
19. Improved outcome in South African children of mixed ethnicity treated for all.
Dippenaar A; Wessels G; Hesseling PB
Pediatr Hematol Oncol; 2006 Jun; 23(4):329-38. PubMed ID: 16621775
[TBL] [Abstract][Full Text] [Related]
20. Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial.
Laver JH; Kraveka JM; Hutchison RE; Chang M; Kepner J; Schwenn M; Tarbell N; Desai S; Weitzman S; Weinstein HJ; Murphy SB
J Clin Oncol; 2005 Jan; 23(3):541-7. PubMed ID: 15659500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
